Charlty reglstratlon number 1141583 IEngland and Wal•s) Company registration numb¥r 07664771 GE.NE PECPLE the genetic conditions support network GENE PEOPLE ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025 • xeinadin GENE PEOPLE LEGAL AND ADMINISTRATIVE INFORMATION Trustees M8 A Palel MrAJ Kènt OBE Mr D Ansel Mr S Milra Mrc J Conway Dr N V TaveFner Dr C H]l￿nk0 (Appointed 18 December 20241 Dr C Steward Mr N L Nicholls Charity numbgr (England and Wales) 1141583 Company number 07564771 Ro918tered offic Nighlingale House 46-48 East st￿et Epsom Surrey United Klngdom Kf17 1HQ Independent gxamlner Hazel Day Xeinadin Nighling8le House 4&48 Easl Street Epsom Sur¥8y KT17 1HQ Sollcltors Stone KiTrg LLP Boundary House 91 Charterhousg Sl Barbican London EC1M 6HR GENE PEOPLE CONTENTS Pagè Trustees, report Inyear plan for the NHS with ils shift In omphasis from Irealmenl lo prevenlion and a ¢ommilmenl lo move heatthcare out of hospiial and closer lo home. NHS England and the DHSC are merging. The Governmènt and Ihe pharma¢tsuli¢al Industry have been deadlocked over price negotiations- the list goes on. For palienis and families with tare genètic conditions and Ihe groups that svpport them all Ihis change h8$ bèèn very unsellling. AllhoLtgh change can often create opportunities. uncertainly about how care anil support will be organized in future is stressful. Throughout the year the team al Gen8 People have Pfovided conllnuily, monitoring proposgd ¢h8ng8s and pulling forward Ihe needs and views of our Partnership Nelwork and the familles they 8UPPOrt lo Government, the NHS and lo Industry and advocating lor positive change. We have also supported the Network through capacity building woik5hops arKI webinars, equipping Ihem with lools that enablè them Éo unclersland belter the changes under way. For indiwduals and families our helpline has provided Invaluablo suppori lor those slruggllng lo find a dlagnosis ol al a loss as lo how lo secure the 8UPPOrt Ihey need. Our cornmilmenl is lo conlinuily, lo being a steady presence supporting our ￿mMunitY as we navigate Ihesè turbulent limes. Ala51alr Kenl Chair of Truslee8. GENE PEOPLE TRUSTEES, REPORT (INCLUDING DIRECTORS, REPORT) (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025 Objectlves and activltles Gene People has a wsion to ImPTove Ihe lives of ihose affected by a genelic condition IhTo¢Jgh the provisron of sources and support both to individuals and families, and lo the hundreds of condition-specific chariiies and palrenl groups Ihal have been eslabllshed in Ihts UK. The objecllves of the charily aro.. the ieligf of persons suffering from genetic dlsorders., the advan¢emonl of medical research Snlo the ¢auses. cure. pr8v&nlion or reh'ef of such dlsorders and the publication of the results of Ihal 185earch,. lo raise awArenes$ and advance thè education of Ihe public on the subject of genetic disordeTS'. lo promole the efficiency and effectiveness of other genetic disorder charities in tstder lo assist Ihem lo achieve Iheir charitable purposes. Publ￿ benefit The Iruslees have paid due regard lo guidance issued by Ihe Charity Commission in deciding what activities the charity should undertake. Achlevaments and perfomiance Significanl activities and achievemenls against objeclives Everything Gene People does conlribules lo achieving Ihre8 Strategio pillars. all of which have been designed lo improve the lives of Ihose livlng with gen&li¢ o)ndillons. The three plllar8 8fe.' Support and Information Slrenglhening condilion-spe¢ific support groups and organlsallon8 Advocacy and Collaboration. The Trustees agreed Ihe followiTHJ Slrdlegic aim5 for 2024-25.. M&inlain focus on income generation through increasing visibility.. the leam have improved the visibility of Gene People by a programme of speaking engagements, 8llending events, responding lo consullalions and increasing the number of partnerships we are involved In. More details Can be found below. As usual, Ra¥e Dlse8se Day was supported by Gene People and our Neiwork Exp8nd div$rslly of incom& lo Include rov8nii8s earned through ¢ontrécts.' Génè People was d81ighled to undèrtake ¢onlracls with Genomlcs England Limited and the North West Genomics Medicine SeTvice Alliance Conlinu8 to improve and develop th8 H8lplino.' th$ lvam have ¢onllnued lo conslder ways In which lo Improve the Helpline and is a member ol the Helpling Partnership - Holdregular webinars on a rAng& of topics forthe Pèrtnersthp Nelwork.. we held a well-received series ofwebinars on'lnfluencing, whieh was kindly funded by Ihe Biolnduslry Association Rare Disease Indystry Group - Hold Iha Gen& P&opl8 Le&d&rship Symposium.. Ihe Symposium look plac8 on 23 Jan 2025 with an audiènce of condilion-specific support groups and charilies, healthcare professionals and sludenls, and Industry. We ale grateful for thè secretarial for Ihl$ event provided by the Association of the Brilish Pharmaceutical Industry - Submil respon$8$ fo ¢on$iilf&llons wilh Input from ourpartnership Nertvoth where possiblg.. Gene People responded lo seveial consu5talions from NICE, the 10 Yeai Health Plan al￿ the Law Commi$slon on Disabled Children's Social Gare. Volunteer support lor Ihls artra is btslng sought . Explom w8ys lo bolh crnale efficiency in ways otworking and betsgr&upport ourindividu8ldonors.' after a lendering process supported by Gene People's Trustee loi Digital Issues, Donorfy was selected as the new cuslomer relalion5hip management system as il offers ways lo increase effKiency and 8UPPOrt lo donLKS. GENE PEOPLE TRUSTEES, REPORT (INCLUDING DIRECTORS, REPORT) (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025 We are a membgr of a range of organisaliDn8 including.. . Associalion of the Br¢tish Pharmaceullcal Industry PalientAdvisory Counc41 Asso¢ialion ol Genetic Nurses and Counsellors Equity Diverslly and Inclusion Subcommiltee Disabled Children's Parlnership - Genèlic Alliance UK Helplines P8rtnershlp - NCVO - NICE Volunlary and Communily Sector Forum Piescr4plion Charges Coalition Spe¢iallsed Health Care Alliancè - Vascular Voice Nelwork. Speaking engagements included Advanced Th8rapies 2024, a conferencé 8t the Royal Sorjety of Medl¢ine and The Klng's Fund Life Sciences Conference. In addition, the team attended a variety of ovents and meelirlgs including Iho Cell and Gene Colleclive, Festival of Genomics. l am numbèr 17 launch event, NHS Genomics Summit, Patients as Partners, Public Policy Projects Genomics conference, and Ihts Scollish Strategic Network foT Genomic Medi¢in8 Palienl Involvemenl Advisory Group. These activities look place alongside the core business ol the Helplina. fundraising and running Ihe chsrily. To fo¢us on the helpline bri8fly, Ihis year the Gene Peoplè genetic counsellor led helpline iesponded lo 141 enquiries from individuals, f8milles and profe$$ionals deallng with a genetic condition. Our genetic counsellor spenl 82 hours on stsppori calls and sent 230 support emails. Enquirers most often contacted the helpline aboul genellc lesling130%1 and lor guidance on how lo access clinic81 genetic seTvice51270A). Emolional supporl was ofton needed. and a11 enquiries w8re managed wilh stsnsilivily and care. Enquiriès were made about 70 differenl genetic condilions. wilh Cyslic Fibiosis being Ihe most common oondilion enqLTrired about. Many olher conditions w810 only enquired about on one o¢¢asion each and are extremely rare diseases. Some of the situations managed ware CA)mplex and required ongoing support Ifom Ihe helpline genetic counsellor Our ongolng pre and post ¢on18cI impacl suryeys showed that 100% 01 those enquirars who responded found their Coniacl wilh the seNice helpful. Some of the feedback recelved Included.. "This is the most wonderful service ftsr families going through th9 Compli￿lI0nS a raie gen81ic diseasels diagnosis brings. Emily was absolutely lovely and I will be back in touch in the future as this is still a very Irieky lime for our family. Many thanks lo the work you do." "I cannot prais& Ihls seNice enough. I couldn'l find anyone l0181k lo about my fears who I fell could talk il through with me bul from an educated perspective, underslandlng my silualion #nd validaling my feelings, until I found this servlce. Thank you.. "Thanks again for your help last month.11 was a prelly excrucialing, isol8ling Ilme and you made11 so easy lor me lo talk freely- I will never forget your kindness lo me. All of this work 1$ not possible wilhoul Ihg kind support of generous donors and fLFndeTS. Whlle the fundraising enVIr￿ment is challenging. Gene Peoplè Is delighted lo have been supported in 2024-25 by.. Amicus Therapeulics GiveAsYouLlve givers London Marathon Runners Parexel Inlernalional Regular and payroll givers And all those who Prefer lo remain anor7ymus. Everyonè at Gene People is do8ply grateful for your support. Togolher, we are Genè People. GENE PEOPLE TRUSTEES, REPORT {INCLUDING DIRECTORS, REPORT) {CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025 Laslly, following Ihe adoption of an Environmental policy which includ85 8 public slalemenl of our carbon emissions. Oar ernissions for financial year 2023-24 were 2.14 lonnes of C02e. This is due to the number of train journeys taken in the year and one relum fllghl lo speak al a conference. The team have actively conlribyled lo evenls and meetings organised by these groups as speaker. chalr or lacililalor. In addition. Gene People has engaged activ8ty with.. . As80¢i8llon of Genelic Nurses and Counsellors European Ra￿ Disease Helpline Network Public Policy Proj8cts. We are proud of Ihe level of work the sThall team has produced (luring the year. Future Plans The Trustees agreed the following slralegic aim8 for 2025-28: Mainlain focus on income gen8ialion Expand number of contracts lo further diversify incoTne Improve the mafkeling ol the H¢lpline Hold Ihe Gene People Leadership Symposium and Increase particlpalion Further develop efficiena8s using technology. such as oplimising the database and Al. GENE PEOPLE TRUSTEES, REPORT (INCLUDING DIRECTORS, REPORT) (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025 Financlal rèviow ReseNespolicy It is Ihe policy Df the charity Ihal unreslricled fund8 which have not been de8ignaled lor 8 spedfic use should b mainlained al a level equivalent lo be￿een Ihree and six monlh's expendilure. The Iruslees con8ider that reseNe$ al this level will ensu￿ Ihal. In Ihtr event of a significant drop in lunding, they will be able lo continue the charity's curRnl aclivilie5 while consideration Is given lo ways which addilional funds may be raised. Trustees Tecognise that Ihe reserves policy has not been achieved and are commilled lo progressing lowafds11. Structur81 governance and management The charity is a company limited by guarantee, as d6fined by the Comp8nies Ac12006, G8n8 Peopl8 changed ils name fmm Genetic Disorders UK IGDUKI in May 2021. The regi8lered charity number (number 11415831 and wrnpany limiied by guaranlee (number 075647711 iemained the Same, Gene People is gDverne¢J by ils memoTandum and 8rticles ol a580clalion dated 15 Mar¢h 2011 and revised 30 April 2025. The charity is controlled by ils governing document, a deed ol tru51, and conslilules a Ilmiled company, lirniled by guaranleo, as defined by Ihe Companies Act 2006. The Iruslees, who Arè 8lsD lh8 directors for the purpose of company law. and who served during the year and LIP to the dale of signature ol the financi815talemenls WO￿. Ms A Palel DrCRuff Mr D G Alklns Mr A J Kent OBE MI DAnsel Mr S Mitra r C J Conway OT N V Tavemei Dr C Hilcenko Dr C Steward Mr N L Nicholls (Resigned 18 Oecember 20241 (Resigned l NovembeT 2024) (Appointed 18 December20241 R&¢mfflm&nl 8ndappoinlment of Iwslees Trusletss serve on tho boafd lor a period of Ihree years Ihat is rnr¢ewable. New Iruslee$ are appotnlecl by Ihe s8rvlng IDJslees, considering the skills requi￿￿ by the board. New Iruslees ale sele¢le(S on the basis of their skills and experien and how these will conlribule lo the charity. They Teceive an in¢Jucllon th31 Includes ontsi8rding m8Elings with the Chair and chlef execulive, as well as a¢cess to key documents and pre*ious board minutes. None ol Ihe Iruslees has any beneficial interest in the company. Al of the INsle8S 8fe members of the ¢ompany and 9uaranlee to contribute £1 in the event of a winding up. GENE PEOPLE TRUSTEES, REPORT (INCLUDING DIRECTORS, REPORT) (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025 Organisalionalslmcture The board oflruslees meets al leasl fourlimes a yearlo rewewprogress and pollaesvia v1deo¢onf￿n¢Ing. Fomial reporbng by the chief execulwe lo the trustees takes place regulaty al board meetings and infom)81ty as appropriate Ihrou9hout the year. The sysiems ol control that are designed lo provide reasonable assurance againsl m8leri81 misslalemenl or loss include., an annLtal budget approved by the Iruslees,. ￿gUlar reiriew ol financAal results. budget varian￿5 and non-finanryal P8rforman¢e indirAlors'. delegation ofauthorily and segregalion olduties., and idenlificatiorb and management ofllsks. There 8re iwo part-lime employees serving as chief executive and genelic counselloi. Other roles are undertaken eithei as needed on an ad hoc basis or through sell-employed consultants. The Iruslees. report was approved by Ihg Board of Trustees. PLL¥ MrAJ Kent OBE Trustee Dal8'. 12 09cember 2025 GENE PEOPLE INDEPENDENT EXAMINER'S REPORT TO THE TRUSTEES OF GENE PEOPLE l report lo the Iruslees on my examirkalion of the fin8n¢ial statements of Gene Peoplè (the charity) lor the year ended 31 March 2025. Re$ponslbllltles and basi5 of report AS the Irusla8s of the charity land also ils directors for the purposes of company lawl, you are responsible for the prep8r8llon ol the finarT¢lal sialemenls in accordance wilh the requirements of the Companies Act 2006. Having satisfied myself that the financial sialemenls of the charity are not required lo be audlled under Parl 16 of the Companies Act 2006 and are trllgible for independent examination, l 18port in respect of my examination of the charity's financial slalemenls carri8d out under seclion 145 01 the Ch8ri1ies Acl 2011. In carrying oul my examlnalion I have followed Ihe Directions given by the Charily Commission under section 14515)(bl ol the Charities Act 2011. Indepqndent examlner's Ststement I have completed my èxamin8tion. I confimi that no mallers havv come lo my allenlion in connecilon wllh Ihg examinallon giving me cause lo believe that in any malerial respect.. accounting records were not kept In rospe¢l of Ihe charity as required by sectlon 386 of the CompaniesAcl 2006. the financial slalemenls do not 8ccord with those records.. or the financial slalemgnls do not comply with the a¢¢ounling ieouirèmènts of secllon 39e of the Companles Act 2006 other than any requirement th81 the financial slalemenls give a true and fair view. which is nol a maller )nsidered as parl ol an independent ex8min8liDn,' or the financial slatements have not been pieparod Sn axordancewilh Ihe methods 8nd principles of the Stalemenl of Reo)mmended Practice lor accounting and reporting by charilies applicable lo chgriliés preparing their financial slalemenls in accotdance wilh Ih? Financial Reporting Standard applicabl8 in Ihe UK ar￿ Republic of Ir81and IFRS 1021. I have no concerns and have come 8cross no olher matters in connedlon with th8 8xaminalion lo which attention should be drdwn in this report in order lo enablts a proper understanding ol the financial statemenls to be reached. Hazel Day Bsc (Honsl FCA DChA Xeinadin Nighling818 House 46-48 East Slreel Epsom Surrey KT171HQ Dal8.. ia.IIF*I.ao.t>.S GENE PEOPLE STATEMENT OF FINANCIAL ACTIVITIES INCLUDING INCOME AND EXPENDITURE ACCOUNT FOR THE YEAR ENDED 31 MARCH 2025 Unr8strlcted Restrlcted fund$ funds 2025 2028 Total Unrestrlcted Restrlcted fundB fund8 2024 2024 Total 2025 2024 Notes Income from: Donallons and legacies OlhBI trading aclivities 53,927 25,708 13,0001 50,927 25,708 43.894 27,585 9.740 53,634 27,585 Total Income 79,635 13,0001 76,635 71,479 9.740 81.219 Expendllure on: Ralsing funds Chari18blè activities 29.174 80,607 29.274 60,607 19,736 44,229 14fj 4,0(YJ 19.882 48.229 Total expendlture 89.781 89,881 63,985 4,146 68,111 Net Incomellexpenditurel and movement In funds (10.1461 13,100) 113.246) 7,514 5,594 13,108 RgconGlllatlon of fund8- Fund b81an¢e8 al l April ￿24 17,775 5,594 23,369 10,261 10.281 Fund balances at31 March 2025 7.629 2.494 10.123 17.775 5.594 23,369 The slalemenl ol financial a¢tsvilles inoludgs all galns and losses recognlsed in the year. All Incom& and expenditure derive Irom wnlinuin9 a¢lSvilles. GENE PEOPLE BALANCE SHEET ASAT31 MARCH2025 2025 2024 Notes current assets Debtors Cash al bank and in hand 10.683 4,774 17,982 24.669 t5.457 42.651 Creditors.. amounts falllng due wlthln one year 12 {5,3341 119,2821 Net current assets 10,123 23.369 The funds of the charlty Reslricled income funds Unr&stri¢ted funds 14 15 2,494 7,629 5.594 17.775 10.f23 23.369 The company is enlitled lo the exemption from the audil ￿quIrement conlalned in section 477 of the Companies Act 2006, for the year ended 31 March 2025. The directors acknowledge their r¢sponsibililies for complylng wllh Ihe requirements of the Companies Act 2006 with respect lo accounting fe¢ords and the preparation of financial slalemenls. The members have not rfjquired Ihe company lo obtain an 8udil of Ils financial slalemenls for the yeai in question in accordanco with secllon 476. These financial sialemenls have been prepared in accordance wlth the provisions appli¢8ble lo companies subjecl lo the small companies iegime. The financial statemenls were approved by the Iruslees on 12 December 2025. fLL¥ MrAJ Kenl OBE Trustee Company regi8lralion number 07564771 (England and Wales) GENE PEOPLE NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025 Ac¢ountlng policigs Charlty Infomiatlon Gene People is a private company limited by guarantee incorporated in England and Wales. The registered office is Nighlingale House. 46-48 East Street, Epsom, sUr￿y, KT17 1Ha, United Kingdom. 1.1 Accountlng convenllon The financial slalemen15 have been prepared in accordance with the charity's goveming document, Ihe Companies Acl 2006, FRS 102'The Financial Reporting Standard applicablè in Ihe UK and RepLJblic of Ireland" and the Chaiili88 SORP Accounling and R¢potling by Ch8rilies'. S181emenl of Re¢omm¢ndgd Pracllce applicable to charities preparing their accounts in accordan￿ wilh the Financial Reporting Standard applicable in the UK and RepubliG of Ireland IFRS 1021" The ¢harity is a Public Benofil Enllly as defined by FRS 102. The chaiily has taken advantage tsf the provlsions In the SORP lor charitiBS not lo preparts a $18lemonl of cash nows. The financial slalemenls are prepaied in slerfing, which is the functional cutteRcy of the charity. Montslary amounts in these financial slalemenls are rounded lo the nearest £. The financial slalemenls have been Prepared under the hi8loTical cost convention. The principal accounllng policies adopted are sel out below. 1.2 Golng concern Al the lime of approwng the finandal 81alemenls, the Iruslees have a ieasonable expectation that the charfly has adequale resources lo continue in operational existence for the foreseeable future. Thus the Iruslees continue lo adopt the going concem basis ol accounting in preparing the financial stalemenls. 1.3 Charilabltr funds Unre51ricted funds are available for uso 81 tho dlscrelion of the Iruslegs In furtherance of Ihelr charitable objective8. R8slficled funds are subiecl lo speafic conditions by donors or granloTS as lo how they may be used. The purposes and uses of the ieslriclèd lutids arè s81 out in thè notès to the finana81 st8t8mènts. 1.4 IFtcomè Income is recognised when Ihe charity is legally enlillod lo it after 8ny p&rfoiman¢o condllions have been mel. the amounts can be measured reliably, and il is probable that income will be received. Cash donations are recognised on receipt. Other donations are recognised once Ihe charity has been notified of the donation, unless performance conditions r@quirÉ deferral ollh8 amounl. Incom8 lax recoverable in relation lo donations received vnder Gift Aid or deeds of covenant Is recognised al the lime of the donallon. Legacies are recognised on receipl or otherwise il the Charity has ￿en noliffied ol an impending dislribulion, the amount is known, and receipt IS 8xpecled. 11 the amounl is nol known, the legacy is Irealed as a conllngenl 8ssel. 10 GENE PEOPLE NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025 Accountlng polici9$ (Contlnuedl 1.5 Expendlturg Expendllure is recognised once there is 8 legal or conslruclve obligation lo Iransler economic benefit lo a IhiTd party. il is piob8ble Ihal 8 transfer of economic benefits will be required in selllemenl, and the amount of Ihe obligation can be measured reli8bly. Expenditure is classified by acliwly. The ￿1$ of each adivily are made up of the 10181 of dir8Ct costs and shaied cosls. including support cosls involved in undertaking each activity. Direal costs allribulable lo a singlB activity are allocated directly lo that aclivily. Shared costs which conlfibule lo more than one activity and support costs which ar8 nol attributable lo a single activily are apportioned be￿een those 8¢1ivili&s on a basis consislenl with the use of resourcès. Cenlral slaff costs are allocated on lh8 basis ol tim8 spent. and depreciation charges are allocated on the portion ol IhB asset's use. 1.6 C88h end cash equivalents Cash and cash equivalents include cash in hand, depostts held al call wllh banks. other short-leTm Ilquld Inveslm8nls with original malurilies of Ihree monlhs or less. and bank overdrafts. Bank ovefdrafts are shown within boirowings In currersl liabilities. 1.7 Flnanclal Instrumgnts The eharily has elected lo apply Ihe provislons of Section 11 'Basic Financl81 Instrumènts. and Section 12'01her Finar¥cial Inslwmènts Issues. ol FRS 102 to all of rfs financlal inslrumenls. Fin8ncial instrumen18 are recogn18¢d in the charity's balanc& sheet wh8n Ih@ charity becorne8 pariy lo Ihe ntr8¢lu81 pmvisions of the inslrumenl. Financial assets and liabili118s are offset, with the nel smounts presanled in the financial slaleTllenls, when there is a legally @nforceable right to Sel off the recognised amounls and there is an inlgnlion lo settle on a nel basls or lo realise Ihe assel and sellle the liability 8imullanèously. Baslc flnanclal assets 8asS¢ financial assets, whlch include d&blors and cash and bank balances, 8rg initially measuied al Iran5aBlion price including Irans8clion costs and are subsequenlly carrted al amortised ￿81 using thè èffeotiv8 inle¥esl melhod unless the 8rrang@ment constitutes a financing Iransaclion. where the Iransaclion Is measured al the present value of the futu￿ rec8ipls discounted al a market r81e of inleresl. Financial assets classified as recelv8ble within on@ yeai are nol amortised. Bas1¢ flnanclalllabilities Basic financial liabilities, includlng creditors and bank loan5 ale inili8lly re¢ognised al Iransaclion price unlèss the arrangem8nl ¢onslilules a financing tranSa￿lOn, where the debt instrument is measured al Ihe present value of the fulure paymenls discounled at a market rale of inl8cesl. FlnanrAal liabilities classified as payable within one year are nol amorlised. Debt in8lfumenls are svbsequentty carried al amorllsed ¢osl. using the effective inleresl rale mèthod. Trade creditors are obligalions to pay for goods OT Services that have been acquired In Ihe ordinary course ol operations from suppliers. Amoun15 payablo are classified as current Ilabllilies if payment is due within one year or less.11 not, Ihèy ar@ presented as nLTrn-cufrenl liabililies. Trade creditors 8re ￿coun1Sed initially al Iransaclion price and svbsequenlly measured al amortl8ed cost using the effeciive interest melhod. Dere¢ognlllon of flnanclal liabllltles Financial liabililies are derecognised when th8 char(Iy's CL)nlractual obligalions expire or are discharge(J or can￿lled. Rellrem*nt beneflts Paymenls to defined conlribulion rellremenl benefit schemes a￿ charged as an expense as they lall due. 11 GENE PEOPLE NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025 Income from donatlons and legacle8 Uniestrlcted Rg$td¢tgd fund$ fijnds 2025 2025 Total Unrnstrlct*d Restrlcted funds funds 2024 2024 Total 2026 2024 Donations and gilts 53,927 {3.000) 50.927 43,894 9,740 53.634 Incom• from other trading actlvltle8 Unreslrictsd Unre$trl¢ted funds funds 2026 2024 Other inccth& 25,708 27,565 Expendlture on ralslng fLFnds Unrestrlcted Restrlcted funds funds 2025 2025 Totsl Unrestrlctèd Re$trlcted fund fund$ 2024 2024 Total 2025 2024 Fundralsing and publlclty Staff Costs 22.862 22,862 16.505 16,505 Trading ¢o$ts Other trading 8Ctivllies 6,312 ICM) 6,412 3.231 146 3,377 TtX81 costs 29,174 l(KJ 29,274 19,736 19,882 12 GENE PEOPLE NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025 Expendlturo on charitable a¢llvltleB Awarenè58 and education 2025 Rellel Totsl Awareness and educatlon 2024 Reli•1 Totsl 2025 2025 2024 2024 Dlrect costs IT cosls HR Services Governano* Insurancè Bank charges Sundry TTavel & subsislen Training & dtrvetopmenl 1,505 550 40 1.764 1,505 550 40 1,764 1.345 1,345 140 2.356 140 2.356 393 1.145 113 393 1,145 113 499 1,535 1.535 5,574 5,574 6.825 6,625 Share of support and governance c05ts18e& note 61 Support 24,082 29,151 Goveman 1.8 53,233 1,800 11,960 3,240 26,404 38.364 3.240 31.458 29,151 60,607 21,825 26,404 48.229 Analys1$ by fund Unrestricled furtds Reslricled funds 31,456 29.151 60,607 17,825 4,000 26,404 44,229 4.000 31,456 29,151 60,607 21,825 26,404 48,229 Support Qosts allocated to aetivitles 2025 2024 s￿ff costs Bookkeeping Legal & professional Governance costs 45,814 38,364 4,259 1,800 3.240 55,033 41.604 Analysed betsYeÈn: Awareness and tsduca1￿n Relief 25,882 29,151 15,2C 26,404 55,033 41.604 13 GENE PEOPLE NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025 Nat movement In funds 2025 2024 The nel moverngnl In funds is slated aftèr char9ingllcfedttingl'. Fees psyabl& for Ihe independent oxaminalion of the ch8r11￿$ financAal $1818menls 1.8 3,240 Trustees None ol the Irustees lor any persons ￿n￿e¢ttrd wllh Ih8ml received any iemuneralion or ben8fits from the charily during tha y8aT. Employee8 The avtrrage monthly numb8r of employee5 flurlng the year was.. 2025 Number 2024 Number Fundraising Chaiilable Total Employment costs 2025 2024 Wages and salaries Social security wsls Olher pension ts)sls 62.847 50.973 4,720 68.476 54,869 Ther¢ were no employe88 whose annual remuneration was more than £60,000. Rèmungration of key management pèrsonnol The remuneration of kèy management personnel was as follows.. 2025 2024 Aggregale compensation 37.e83 27,818 10 Taxation The chaTily is exempt from taxalion on ils activities b￿V$e all 118 income is applied for Chaiitable purposes. 14 GENE PEOPLE NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025 11 Debtors 2025 2024 Amounts falling due wlthln one yèar: Tr8d8 debtors Other debloTS Prepaymènls and ac(¥ued In¢ome 2,500 6,263 1,920 7,625 8,763 1,594 10,683 17,982 12 Credltor8: amounts falllng due wlthlrF one year 2025 2024 Olhor lax8￿.0n and soclal secuiity Trade creditors Other uedilors Accruals and deferred Income 3,709 263 2,332 87 15,723 1,140 1,202 5,334 19,282 13 Retlrem¥nt b¢noflt scheme5 2025 2024 Deflned contrlbutlon s¢hwn•s Charge lo profil or loss in rèspect of deflned contribution scheme8 4,720 3,896 The charily operales a definéd conlribulion pen$lon scheme. The assets of the scheme are held s8paralely liom those ol the charity in Ind¢pondenlly admlnS8ler8d funds. Th8 penslon costs charge repr8ser*ls ¢onlribulitsns payablè by the group lo the funds and amounted 10 £4,720 {2024'. £3.8981. There ar¢ no conlribulions payable lo thè funds al Ihe year end12024= £4361. Th& expense and liability have b88n Fecognised in unreslfS¢led funds. 14 Restrl¢ted funds The reslricled funds of thè charily compriso the unexpended balances of donations and grants held on Irusl 8uble¢l lo specific condllions by donois as lo how they may be used. At l Aprll 2024 Incomlng resou￿05 Resources At 31 March expended 202 Symposium 5,594 13.000) 11LXJI 2,494 15 GENE PEOPLE NOTES TO THE FINANCIAL STATEMENTS {CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025 14 RgStrl¢ted funds IContlnu9dl Pravlous year.. At 1 April 2023 Incoming re8ourcè$ Resourcès At 31 Ma￿h 8xpended 2024 Symposium Helpline 5.740 4.000 11461 14,0(M)I 5,594 9,740 (4.1461 5,594 15 Unre$tflctod funds The unreslri¢ted funds of Iha charily comprise the unexpended balances of don81ions and grants which are not 5ubje¢t lo specific conditions by donoTS and granlot8 as lo how Ihey may be used. These Include designated funds which have been sèl asido oul of unreslricted funds by the trustees for sperAfic purposes. At l Aprll 2024 Incomlng re8OUfces Resources At 31 March expandgd 2025 Gener81 f￿d 17,775 79.635 189.7811 7,629 Prgvlous year: At 1 April 2023 Incoming resources Resources At 31 MBrch xponded 2024 General fund 10,281 71,479 ie3,9651 17,775 16 Analy816 of net 8$Sgts botsyeen funds Unrgstrlcted fund5 2025 Reytrlctèd fund$ 2025 Total 2026 At 31 March 2025.. Cufienl asselsllliablliliesl 7.629 2,494 10,123 7,629 2.494 10,123 Unr8stricled funds 2021 Re6trlcted fund8 2024 Totsl 2024 At31 March 2024: Current assetsllliabililiesl 17.775 5,594 23,369 17.775 5,594 23,369 16 GENE PEOPLE NOTES TO THE FINANCIAL STATEMENTS {CONTINUED) FOR THE YEAR ENDED 31 MARCH 2025 17 Rglated party tr8n8actlons Theie wero no disdosabte related party transactions during Ihe year12024- non&l. 18 Company Status The charity is a piivale company lirniled by guarantee. The members of the company are the Iruslees named on page 1. In the evenl ol the charity belng wound up the Ilabllily in respect of Ihe guarantee is limlled lo £1 per membei ol the charity. 17